Region | Control (102) | MDMA–2 weeks (102) | % Control | MDMA–7 years (102) | % Control |
---|---|---|---|---|---|
Neocortex | |||||
CFA | 647 ± 22 | 42 ± 10 | 7a,c | 410 ± 73 | 63a,b |
CCA | 753 ± 31 | 96 ± 34 | 13a,c | 467 ± 52 | 62a,b |
CTp1 | 597 ± 46 | 31 ± 8 | 5a,c | 361 ± 44 | 60a,b |
CTp2 | 621 ± 70 | 36 ± 11 | 6a,c | 385 ± 46 | 62a,b |
CIs1 | 812 ± 34 | 118 ± 21 | 15a,c | 526 ± 40 | 65a,b |
CIs2 | 841 ± 22 | 125 ± 31 | 15a,c | 559 ± 11 | 66a,b |
CPf1 | 833 ± 30 | 144 ± 18 | 17a,c | 477 ± 63 | 57a,b |
CPf2 | 786 ± 72 | 116 ± 20 | 15a,c | 343 ± 46 | 44a,b |
CPa | 640 ± 49 | 70 ± 20 | 11a,c | 415 ± 30 | 65a,b |
CSt | 758 ± 60 | 64 ± 23 | 9a,c | 347 ± 14 | 46a,b |
Striatum | |||||
Cd1 | 149 ± 11 | 10 ± 0.6 | 72-a | 50 ± 17 | 342-a |
Cd2 | 210 ± 11 | 18 ± 0.1 | 92-a | 51 ± 5 | 242-a |
Cd3 | 167 ± 25 | 12 ± 0.2 | 82-a | 50 ± 4 | 302-a |
Put1 | 300 ± 41 | 53 ± 19 | 182-a | 155 ± 56 | 522-a |
Put2 | 251 ± 13 | 34 ± 4 | 142-a | 108 ± 17 | 432-a |
Put3 | 222 ± 25 | 34 ± 4 | 152-a | 118 ± 1.8 | 532-a |
Globus pallidus | |||||
GPex | 527 ± 20 | 203 ± 21 | 39a,c | 1069 ± 37 | 203a,b |
GPin | 766 ± 30 | 391 ± 64 | 51a,c | 902 ± 61 | 128a,b |
Limbic regions | |||||
DS | 150 ± 14 | 85 ± 21 | 562-a | 161 ± 2 | 1072-b |
LS | 273 ± 33 | 198 ± 12 | 72 | 355 ± 37 | 1302-b |
TOf | 454 ± 13 | 97 ± 10 | 21a,c | 486 ± 92 | 1072-b |
TOm | 325 ± 33 | 102 ± 30 | 31a,c | 339 ± 48 | 1042-b |
ASt | 384 ± 41 | 141 ± 39 | 37a,c | 398 ± 56 | 1042-b |
BAM | 360 ± 36 | 135 ± 64 | 38a,c | 245 ± 17 | 68 |
BAL | 605 ± 62 | 130 ± 23 | 22a,c | 510 ± 65 | 842-b |
BLA | 793 ± 56 | 228 ± 12 | 29a,c | 522 ± 13 | 66a,b |
BMA | 705 ± 47 | 99 ± 8 | 142-a | 262 ± 50 | 402-a |
CeA | 494 ± 61 | 171 ± 17 | 35a,c | 487 ± 46 | 982-b |
LA | 762 ± 80 | 34 ± 8 | 52-a | 326 ± 29 | 432-a |
Hypothalamus | |||||
ADH | 1114 ± 16 | 510 ± 91 | 46a,c | 999 ± 123 | 902-b |
DmH | 1015 ± 25 | 619 ± 96 | 612-a | 926 ± 122 | 91 |
VmH | 934 ± 82 | 602 ± 75 | 642-a | 957 ± 166 | 102 |
ALH | 1127 ± 92 | 1111 ± 103 | 99 | 1201 ± 95 | 107 |
Thalamus | |||||
VA | 302 ± 37 | 63 ± 11 | 21a,c | 459 ± 115 | 152a,b |
AV | 454 ± 53 | 40 ± 2 | 92-a | 250 ± 16 | 552-a |
LD | 515 ± 77 | 35 ± 5 | 72-a | 249 ± 6 | 48 |
MD | 727 ± 27 | 82 ± 3 | 11a,c | 673 ± 71 | 932-b |
VLo | 586 ± 14 | 37 ± 10 | 6a,c | 642 ± 137 | 1102-b |
VL | 884 ± 22 | 64 ± 5 | 6a,c | 682 ± 117 | 772-b |
VPI | 290 ± 31 | 27 ± 1 | 9a,c | 366 ± 38 | 126a,b |
Hippocampus | |||||
FD | 343 ± 28 | 195 ± 18 | 572-a | 190 ± 47 | 552-a |
CA1 | 273 ± 23 | 83 ± 7 | 302-a | 157 ± 27 | 572-a |
CA2 | 773 ± 36 | 365 ± 54 | 472-a | 495 ± 61 | 642-a |
CA3 | 225 ± 14 | 102 ± 10 | 462-a | 149 ± 40 | 66 |
Sbc | 342 ± 24 | 25 ± 5 | 82-a | 67 ± 24 | 202-a |
Other regions | |||||
ZI | 427 ± 22 | 289 ± 12 | 682-a | 475 ± 39 | 121 |
MM | 1239 ± 72 | 232 ± 48 | 19a,c | 623 ± 49 | 50a,b |
IC | 18 ± 3 | 5 ± 1 | 322-a | 9 ± 0.1 | 512-a |
MDMA was given subcutaneously at a dose of 5 mg/kg twice daily for 4 consecutive days. Values represent the mean ± SEM and are expressed in pixels.
↵F2-a Designates significantly different from control.
↵F2-b Designates significantly different from 2 week survival.
F2-c Designates significantly different from 7 year survival.